Decision making in the treatment of benign parotid tumors

.ical

09-09, 16:30–17:00 (Europe/Istanbul), Head & Neck Oncology 1

Jan Plzak

<p>Head of Department of Otorhinolaryngology and Head and Neck Surgery</p> <p>1st Faculty of Medicine, Charles University, Motol University Hospital</p> <p>Prague, CZECH REPUBLIC</p> <p>Chairman</p> <p>Czech Society of Otorhinolaryngology and Head and Neck Surgery</p> <p>President</p> <p>CEORL-HNS Confederation of European Otorhinolaryngology-Head and Neck Surgery, www.ceorlhns.org</p> <p>Fellow of the European Board of Otorhinolaryngology Head and Neck Surgery – FEBORL-HNS (Hon)</p> <p>Scientifric Interest: Head and Neck Oncology, Thyroid, Salivary Gland, Rhinology, Skull Base</p>

This speaker also appears in:

• Contemporary Management of Advanced or Poorly Differentiated Thyroid Cancer
• New Perspectives in Chronic Sinusitis
• CEORL-HNS Update on Benign Sinonasal Tumors

Ben-Zion Joshua

<p></p>

This speaker also appears in:

• Contemporary Management of Advanced or Poorly Differentiated Thyroid Cancer
• Primary Hyperparathyroidism 2026: Patient Selection, the Essential Imaging Algorithm, Decision-Making and Intraoperative Adjuncts